Discovery of dihydropyridinone derivative as a covalent EZH2 degrader

被引：2

作者：

Zhou, Bin ^{[1
,2
]}

Wang, Beilei ^{[1
,3
,4
]}

Zou, Fengming ^{[1
,3
,4
]}

Mei, Husheng ^{[1
,2
]}

Liu, Qingwang ^{[1
,3
,4
]}

Qi, Shuang ^{[1
,3
,4
,5
]}

Wang, Wenliang ^{[1
,5
]}

Jin, Rui ^{[1
,3
]}

Wang, Aoli ^{[1
,3
,4
]}

Chen, Yongfei ^{[1
,3
,4
]}

Liu, Feiyang ^{[1
,4
,5
]}

Wang, Wenchao ^{[1
,2
,3
,4
,5
]}

Liu, Jing ^{[1
,2
,3
,4
,5
,6
]}

Liu, Qingsong ^{[1
,2
,3
,4
,5
,6
]}

机构：

[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China

[2] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China

[3] Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China

[4] Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[5] Primary Cell Engn Joint Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[6] Chinese Acad Sci, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 261卷

基金：

中国国家自然科学基金;

关键词：

Enhancer of zeste homolog 2; Covalent inhibitor; EZH2; degrader; HISTONE METHYLTRANSFERASE EZH2; LYSINE; 27; POLYCOMB; INHIBITOR; LYMPHOMA; COMPLEX; DESIGN; HYPERTRIMETHYLATION; IDENTIFICATION; METHYLATION;

D O I：

10.1016/j.ejmech.2023.115825

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

EZH2 is overexpressed in multiple types of cancer and high expression level of EZH2 correlates with poor prognosis. Besides the regulation of H3K27 trimethylation, EZH2 itself regulates its downstream proteins in a PRC2-and methylation-independent way. Starting from an approved EZH2 inhibitor EPZ-6438, we used covalent drug design and medicinal chemistry approaches to discover a novel covalent EZH2 degrader 38, which forms a covalent bond with EZH2 Cys663 and showed strong biochemical activities against EZH2 WT and mutants. Compound 38 exhibited potent antiproliferation effects against both B-cell lymphoma and TNBC cell lines by reducing the levels of H3K27me3 and EZH2. The mass spectrometry, washout and competition experiments confirmed the covalent binding of 38 to EZH2. This study demonstrates that covalent EZH2 degraders could provide an opportunity for the development of promising new drug candidates.

引用

页数：23

共 50 条

[41] EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
Campbell, John E.
Kuntz, Kevin W.
Knutson, Sarah K.
Warholic, Natalie M.
Keilhack, Heike
Wigle, Tim J.
Raimondi, Alejandra
Klaus, Christine R.
Rioux, Nathalie
Yokoi, Akira
Kawano, Satoshi
Minoshima, Yukinori
Choi, Hyeong-Wook
Scott, Margaret Porter
Waters, Nigel J.
Smith, Jesse J.
Chesworth, Richard
Moyer, Mikel P.
Copeland, Robert A.
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (05): : 491 - 495
[42] Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Liu, Qipeng
Wang, Guangyu
Li, Qiaqia
Jiang, Weihua
Kim, Jung-Sun
Wang, Rui
Zhu, Sen
Wang, Xiaoju
Yan, Lin
Yi, Yang
Zhang, Lili
Meng, Qingshu
Li, Chao
Zhao, Dongyu
Qiao, Yuanyuan
Li, Yong
Gursel, Demirkan B.
Chinnaiyan, Arul M.
Chen, Kaifu
Cao, Qi
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (02) : 415 - 426
[43] Docking and 3D-QSAR Analysis on a Series of Pyridone-based EZH2 Inhibitors
Xiong Di
Ma Yu-Zhuo
Zhao Zhong-Xiang
Liu Ying-Xiang
Xiang Yao
CHINESE JOURNAL OF STRUCTURAL CHEMISTRY, 2017, 36 (04) : 575 - 588
[44] Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2
Zhang, Yi
Yang, Hong
Li, Bingbing
Li, Jiayi
Li, Huaxuan
Shi, Qiongyu
Li, Bang
Wang, Zekun
Zheng, Jiahong
Zhang, Ying
Dong, Hui
Huang, Xun
Wang, Yuanxiang
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (11) : 7629 - 7644
[45] Targeting histone methyltransferase EZH2 as cancer treatment
Kondo, Yutaka
JOURNAL OF BIOCHEMISTRY, 2014, 156 (05) : 249 - 257
[46] EZH2 serves as a promising therapeutic target for fibrosis
Zhang, Qian
Wu, Ya-Xi
Yu, Xiao-Qian
Zhang, Bao-Yin
Ma, Li-Ying
BIOORGANIC CHEMISTRY, 2023, 137
[47] Emerging role of EZH2 in solid tumor metastasis
Verma, Ayushi
Khan, Muqtada Ali
Satrusal, Saumya Ranjan
Datta, Dipak
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (01):
[48] Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons
Henriquez, Berta
Bustos, Fernando J.
Aguilar, Rodrigo
Becerra, Alvaro
Simon, Felipe
Montecino, Martin
van Zundert, Brigitte
MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 57 : 130 - 143
[49] Dual-target EZH2 inhibitor: latest advances in medicinal chemistry
Wei, Lai
Mei, Dan
Hu, Sijia
Du, Shufang
FUTURE MEDICINAL CHEMISTRY, 2024, 16 (15) : 1561 - 1582
[50] EZH2 is essential for development of mouse preimplantation embryos
Huang, Xian-Ju
Wang, Xuguang
Ma, Xueshan
Sun, Shao-Chen
Zhou, Xiaolong
Zhu, Chengcheng
Liu, Honglin
REPRODUCTION FERTILITY AND DEVELOPMENT, 2014, 26 (08) : 1166 - 1175

← 1 2 3 4 5 →